238 related articles for article (PubMed ID: 9350925)
21. Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial).
Lincoff AM; Bittl JA; Kleiman NS; Sarembock IJ; Jackman JD; Mehta S; Tannenbaum MA; Niederman AL; Bachinsky WB; Tift-Mann J; Parker HG; Kereiakes DJ; Harrington RA; Feit F; Maierson ES; Chew DP; Topol EJ;
Am J Cardiol; 2004 May; 93(9):1092-6. PubMed ID: 15110198
[TBL] [Abstract][Full Text] [Related]
22. A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial.
Gibson CM; Morrow DA; Murphy SA; Palabrica TM; Jennings LK; Stone PH; Lui HH; Bulle T; Lakkis N; Kovach R; Cohen DJ; Fish P; McCabe CH; Braunwald E;
J Am Coll Cardiol; 2006 Jun; 47(12):2364-73. PubMed ID: 16781360
[TBL] [Abstract][Full Text] [Related]
23. Bivalirudin during primary PCI in acute myocardial infarction.
Stone GW; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Kornowski R; Hartmann F; Gersh BJ; Pocock SJ; Dangas G; Wong SC; Kirtane AJ; Parise H; Mehran R;
N Engl J Med; 2008 May; 358(21):2218-30. PubMed ID: 18499566
[TBL] [Abstract][Full Text] [Related]
24. Bivalirudin: a new approach to anticoagulation.
Nawarskas JJ; Anderson JR
Heart Dis; 2001; 3(2):131-7. PubMed ID: 11975781
[TBL] [Abstract][Full Text] [Related]
25. Clinical pharmacology of bivalirudin.
Reed MD; Bell D
Pharmacotherapy; 2002 Jun; 22(6 Pt 2):105S-111S. PubMed ID: 12064567
[TBL] [Abstract][Full Text] [Related]
26. Direct thrombin inhibition appears to be a safe and effective anticoagulant for percutaneous bypass graft interventions.
Kao J; Lincoff AM; Topol EJ; Madrid A; J Price M; Sawhney N; Teirstein PS
Catheter Cardiovasc Interv; 2006 Sep; 68(3):352-6. PubMed ID: 16892428
[TBL] [Abstract][Full Text] [Related]
27. Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.
Campbell KR; Mahaffey KW; Lewis BE; Weitz JI; Berkowitz SD; Ohman EM; Califf RM
J Invasive Cardiol; 2000 Dec; 12 Suppl F():14F-9. PubMed ID: 11156729
[No Abstract] [Full Text] [Related]
28. Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial.
Cohen DJ; Lincoff AM; Lavelle TA; Chen HL; Bakhai A; Berezin RH; Jackman D; Sarembock IJ; Topol EJ
J Am Coll Cardiol; 2004 Nov; 44(9):1792-800. PubMed ID: 15519009
[TBL] [Abstract][Full Text] [Related]
29. Use of low-dose heparin with bivalirudin for ad-hoc transradial coronary interventions: experience from a single center.
Singh A; Edasery D; Noor A; Bhasin N; Kaplan B; Jauhar R
J Invasive Cardiol; 2011 Mar; 23(3):101-4. PubMed ID: 21364238
[TBL] [Abstract][Full Text] [Related]
30. Bivalirudin vs heparin in percutaneous coronary intervention: a pooled analysis.
Ebrahimi R; Lincoff AM; Bittl JA; Chew D; Wolski K; Wadhan N; Toggart EJ; Topol EJ
J Cardiovasc Pharmacol Ther; 2005 Dec; 10(4):209-16. PubMed ID: 16382257
[TBL] [Abstract][Full Text] [Related]
31. The safety and effectiveness of bivalirudin in female patients with acute myocardial infarction undergoing primary angioplasty: A subgroup analysis of the BRIGHT trial.
Liang Z; Li Y; Wang J; Wang D; Wang S; Ma L; Liu H; Yang L; Stone GW; Han Y
Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():608-15. PubMed ID: 26762481
[TBL] [Abstract][Full Text] [Related]
32. Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty: A meta-analyis of randomised trials.
De Luca G; Cassetti E; Verdoia M; Marino P
Thromb Haemost; 2009 Sep; 102(3):428-36. PubMed ID: 19718462
[TBL] [Abstract][Full Text] [Related]
33. Bivalirudin versus heparin for percutaneous coronary intervention: an updated meta-analysis of randomized controlled trials.
Lipinski MJ; Lhermusier T; Escarcega RO; Baker NC; Magalhães MA; Torguson R; Suddath WO; Satler LF; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2014; 15(6-7):315-22. PubMed ID: 25440505
[TBL] [Abstract][Full Text] [Related]
34. Evolution of improved antithrombotic and antiplatelet agents: genesis of the Comparison of Abciximab Complications with Hirulog [and back-Up Abciximab] Events Trial (CACHET).
Topol EJ
Am J Cardiol; 1998 Oct; 82(8B):63P-68P. PubMed ID: 9809894
[TBL] [Abstract][Full Text] [Related]
35. FDA panel votes against approval for bivalirudin.
Piña I
Circulation; 1999 Mar; 99(10):1277. PubMed ID: 10077507
[No Abstract] [Full Text] [Related]
36. Prognostic value of a high on-clopidogrel treatment platelet reactivity in bivalirudin versus abciximab treated non-ST-segment elevation myocardial infarction patients. ISAR-REACT 4 (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment-4) platelet substudy.
Sibbing D; Bernlochner I; Schulz S; Massberg S; Schömig A; Mehilli J; Kastrati A
J Am Coll Cardiol; 2012 Jul; 60(5):369-77. PubMed ID: 22682553
[TBL] [Abstract][Full Text] [Related]
37. Anticoagulation with bivalirudin during percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Stella JF; Stella RE; Iaffaldano RA; Stella DJ; Erickson KW; Bliley RC
J Invasive Cardiol; 2004 Sep; 16(9):451-4. PubMed ID: 15353822
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcomes of bivalirudin for ischemic heart disease.
Kong DF; Topol EJ; Bittl JA; White HD; Théroux P; Hasselblad V; Califf RM
Circulation; 1999 Nov; 100(20):2049-53. PubMed ID: 10562259
[TBL] [Abstract][Full Text] [Related]
39. Bivalirudin for percutaneous coronary intervention and in acute coronary syndromes.
Bates ER
Curr Cardiol Rep; 2001 Sep; 3(5):348-54. PubMed ID: 11504570
[TBL] [Abstract][Full Text] [Related]
40. Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in high-risk patients undergoing percutaneous coronary intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin study).
Patti G; Pasceri V; D'Antonio L; D'Ambrosio A; Macrì M; Dicuonzo G; Colonna G; Montinaro A; Di Sciascio G
Am J Cardiol; 2012 Aug; 110(4):478-84. PubMed ID: 22583760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
